Detalhe da pesquisa
1.
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.
Blood
; 143(11): 1006-1017, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142424
2.
Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group.
Br J Haematol
; 204(5): 1894-1898, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279625
3.
CXCR4 PET/MRI for follow-up of gastric mucosa-associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication.
Blood
; 139(2): 240-244, 2022 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525196
4.
Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3.
Br J Haematol
; 203(4): 678-683, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646304
5.
Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcoma.
Haematologica
; 2023 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994105
6.
Neuropathological Variability within a Spectrum of NMDAR-Encephalitis.
Ann Neurol
; 90(5): 725-737, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562035
7.
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
Blood
; 134(14): 1132-1143, 2019 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292114
8.
Molecular features of non-anaplastic peripheral T-cell lymphoma in children and adolescents.
Pediatr Blood Cancer
; 68(11): e29285, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34390161
9.
Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma.
Acta Derm Venereol
; 101(2): adv00383, 2021 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33475146
10.
miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels.
Blood
; 132(22): 2389-2400, 2018 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30213873
11.
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy.
Blood
; 132(7): 694-706, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29907599
12.
Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis.
Haematologica
; 105(2): 366-374, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018976
13.
Biological properties of bone marrow plasma cells influence their recovery in aspirate specimens: impact on classification of plasma cell disorders and potential bias to evaluation of treatment response.
Ann Hematol
; 99(11): 2599-2609, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935190
14.
Treatment with brentuximab vedotin plus bendamustine in unselected patients with CD30-positive aggressive lymphomas.
Eur J Haematol
; 104(3): 251-258, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31838747
15.
Management of children and adolescents with gray zone lymphoma: A case series.
Pediatr Blood Cancer
; 67(5): e28206, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32037692
16.
Transformed mucosa-associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction-based clonality analysis.
Br J Haematol
; 186(3): 448-459, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31124124
17.
First-in-human response of BCL-2 inhibitor venetoclax in T-cell prolymphocytic leukemia.
Blood
; 130(23): 2499-2503, 2017 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28972014
18.
Prolonged follow-up on lenalidomide-based treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)-Real-world data from the Medical University of Vienna.
Hematol Oncol
; 37(4): 345-351, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31283840
19.
Treatment of mucosa associated lymphoid tissue lymphoma with a long-term once-weekly regimen of oral azithromycin: Results from the phase II MALT-A trial.
Hematol Oncol
; 37(1): 22-26, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30153341
20.
Gastrointestinal Involvement in Patients with Mantle Cell Lymphoma: A Single Center Experience of Eighty-Five Patients.
Dig Dis
; 37(3): 194-200, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30677768